Prerenal Aki
Prerenal Aki - Related Videos
18:10
Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
0 Views •
Cited by 40 •
2011
The present article describes the steps required to isolate and characterize RNA polymerase fidelity variants of RNA viruses and how to use mutation frequency data to confirm fidelity changes in tissue culture.
11:55
Streamlined Sampling and Cultivation of the Pelagic Cosmopolitan Larvacean, Oikopleura dioica
0 Views •
Cited by 14 •
2020
Oikopleura dioica is a tunicate model organism in various fields of biology. We describe sampling methods, species identification, culturing setup, and culturing protocols for the animals and algal feed. We highlight key factors that helped strengthen the culture system and discuss the possible problems and resolutions.
07:31
In vivo Micro-circulation Measurement in Skeletal Muscle by Intra-vital Microscopy
0 Views •
Cited by 5 •
2007
A new versatile method for observation of microcirculation is presented. It is considered suitable for long-term observation, and for combination with pharmacophysiological or molecular biological interventions.
06:05
Integrated Bone Formation Through In Vivo Endochondral Ossification Using Mesenchymal Stem Cells
0 Views •
2023
Bone therapy via endochondral ossification by implanting artificial cartilage tissue produced from mesenchymal stem cells has the potential to circumvent the drawbacks of conventional therapies. Hyaluronic acid hydrogels are effective in scaling up uniformly differentiated cartilage grafts as well as creating integrated bone with vascularization between fused grafts in vivo.
10:06
Phagocytosis Assay for Apoptotic Cells in Drosophila Embryos
0 Views •
2017
We herein describe a phagocytosis assay using the dispersed embryonic cells of Drosophila. It enables us to easily and precisely quantify in vivo phagocytosis levels, and to identify new molecules required for the phagocytosis of apoptotic cells.
FAQs
Reduced renal blood flow activates both the renin-angiotensin-aldosterone system and the sympathetic nervous system. These responses promote sodium and water retention, helping preserve circulating volume when perfusion falls. Although compensatory, they signal that the kidneys are responding to reduced delivery of blood rather than an initial structural tissue injury. This mechanism explains why correcting circulation can improve kidney function.
These conditions reduce effective renal perfusion, but they do so through different clinical problems. Dehydration and blood loss lower circulating volume, while heart failure can reduce cardiac output. Sepsis can also impair effective circulation. Despite these varied causes, the common consequence is reduced renal blood flow and glomerular filtration, which produces the same perfusion-related pattern of dysfunction.
The early functional disturbance may be reversible when renal perfusion is restored, but persistent inadequate circulation can cause the problem to progress beyond an initial perfusion deficit. The overview emphasizes that timely treatment helps prevent progression to intrinsic kidney injury, in which kidney tissue becomes involved. This makes early recognition and correction of the underlying cause clinically important.
Prerenal AKI begins with inadequate renal perfusion and no initial structural damage to kidney tissue, whereas intrinsic kidney injury represents progression involving the kidney itself. This distinction matters because the early prerenal process may improve when circulation is restored. If low perfusion persists, however, the initially functional problem can develop into structural injury and become more difficult to reverse.
Management starts by recognizing reduced kidney function in the setting of inadequate circulation, then identifying and correcting the cause. Clinical priorities include restoring circulation, addressing dehydration, blood loss, heart failure, or sepsis as appropriate, and avoiding nephrotoxic exposures. Acting promptly targets the perfusion problem directly and may reverse dysfunction before intrinsic kidney injury develops.
Recognition is particularly important when a patient has a condition that can reduce circulating volume or cardiac output, including dehydration, blood loss, heart failure, or sepsis. In these settings, clinicians can focus on correcting the underlying circulatory problem and limiting nephrotoxic exposures. The goal is not only to improve current kidney function but also to prevent progression to intrinsic injury.